Henry Ma Selected Research

Henry Ma Research Topics

41	Stroke (Strokes) 02/2022 - 03/2009
34	Ischemic Stroke 01/2022 - 03/2009
10	Infarction (Infarctions) 01/2018 - 05/2006
5	Encephalitis (Encephalitis, Rasmussen) 01/2022 - 01/2018
4	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2022 - 01/2014
3	Hemorrhage 12/2022 - 12/2010
3	Inflammation (Inflammations) 01/2022 - 01/2016
2	Infections 01/2022 - 01/2020
2	Transient Ischemic Attack 01/2021 - 01/2015
2	Central Nervous System Infections (Central Nervous System Infection) 01/2021 - 01/2020
2	Cerebral Hemorrhage 01/2019 - 06/2011
2	Body Weight (Weight, Body) 01/2018 - 03/2015
2	Brain Ischemia (Cerebral Ischemia) 01/2018 - 05/2012
2	Osteoarthritis 01/2016 - 01/2016
1	Epistaxis (Nosebleed) 12/2022
1	COVID-19 05/2022
1	Neoplasms (Cancer) 01/2022
1	Deglutition Disorders (Dysphagia) 01/2021
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021
1	Viral Encephalitis 01/2021
1	Wounds and Injuries (Trauma) 12/2020
1	Fever (Fevers) 11/2019
1	Neurologic Manifestations (Neurological Manifestations) 01/2019
1	Seizures (Absence Seizure) 01/2019
1	Brain Injuries (Brain Injury) 08/2018
1	Carcinogenesis 08/2018
1	Thrombosis (Thrombus) 01/2018
1	Coma (Comas) 01/2018
1	Cerebral Infarction 01/2018
1	Heart Arrest (Cardiac Arrest) 01/2018
1	Pain (Aches) 01/2016
1	Lacunar Stroke 01/2016
1	Urinary Tract Infections (Urinary Tract Infection) 10/2015
1	Dehydration (Water Stress) 10/2015
1	Peripheral Arterial Disease 01/2015
1	Atherosclerosis 01/2015
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 12/2010

26	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 03/2009
6	Tenecteplase FDA Link 01/2022 - 01/2018
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2011
5	Biological ProductsIBA 01/2020 - 03/2009
4	AerosolsIBA 01/2022 - 11/2019
2	Tranexamic Acid (AMCA)FDA Link 01/2022 - 12/2020
2	ChemokinesIBA 01/2022 - 01/2021
2	VaccinesIBA 01/2021 - 01/2020
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 02/2020 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2015
2	Complement System Proteins (Complement)IBA 01/2020 - 01/2016
2	Amyloid (Amyloid Fibrils)IBA 05/2012 - 12/2010
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 05/2012 - 12/2010
1	FibrinIBA 05/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2022
1	Viral RNAIBA 01/2022
1	CytokinesIBA 01/2021
1	Edetic Acid (EDTA)FDA Link 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	ClusterinIBA 01/2020
1	VitronectinIBA 01/2020
1	Complement C9 (Complement Component 9)IBA 01/2020
1	Tight Junction ProteinsIBA 10/2019
1	MucinsIBA 10/2019
1	CXCR ReceptorsIBA 01/2018
1	CholesterolIBA 06/2017
1	ProteomeIBA 01/2016
1	Cytidine Triphosphate (CTP)IBA 01/2016
1	CateninsIBA 01/2016
1	CreatinineIBA 10/2015
1	SPADIBA 01/2015
1	Cilostazol (Pletal)FDA LinkGeneric 01/2015
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2015
1	Neuroprotective AgentsIBA 06/2011
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 06/2011
1	LigandsIBA 12/2010
1	Desmodus rotundus salivary plasminogen activator alpha 1IBA 03/2009

21	Therapeutics 01/2022 - 05/2006
12	Thrombectomy 01/2022 - 03/2015
3	Thrombolytic Therapy 12/2020 - 06/2011
2	Secondary Prevention 02/2022 - 01/2015
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019 - 01/2018
1	Transjugular Intrahepatic Portasystemic Shunt 12/2022
1	Transportation of Patients 01/2022
1	Length of Stay 12/2020
1	Ambulatory Care (Outpatient Care) 01/2019
1	Cardiopulmonary Resuscitation (CPR) 01/2019
1	Contraindications 01/2018
1	Intravenous Infusions 01/2018
1	Intravenous Injections 01/2018
1	Catheters 01/2018
1	Induced Hypothermia 01/2018
1	Stents 03/2015